Canadian Town of Asbestos Changing Its Name for Economics
Officials in Asbestos, Quebec, have been struggling for years to develop a new identity for the small Canadian mining town. Changing its name might do the trick. Mayor Hugues Grimard announced recently that his town in southeastern Quebec is looking for a name change in 2020, believing it could spark a much-needed economic recovery. The natural link between the town’s name and the toxic mineral — once so compelling — has become a roadblock to any future development. Exposure to asbestos can lead to deadly diseases, including mesothelioma cancer. “There is really a negative perception around asbestos...
Source: Asbestos and Mesothelioma News - December 9, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Comparative Study Reveals Best Mesothelioma Surgery
Less is usually better than more when it comes to aggressive surgery for pleural mesothelioma, according to the latest and most-extensive comparative study. Throughout the last 25 years, surgical patients typically fared better with the lung-sparing pleurectomy and decortication (P/D) than with the more radical extrapleural pneumonectomy (EPP). “We found that the P/D approach should be preferred when technically feasible,” Dr. Dimitrios Magouliotis of the General University Hospital of Larissa in Greece, told The Mesothelioma Center at Asbestos.com. “We believe now the P/D should be the first choice.&rdqu...
Source: Asbestos and Mesothelioma News - December 5, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

DaSilva Building Mesothelioma Specialty Program in Orlando
Thoracic surgeon Dr. Marcelo DaSilva came to Orlando, Florida, with a lofty goal. He wants to make Central Florida a destination for patients diagnosed with malignant pleural mesothelioma. DaSilva also has the tools to make that goal a reality, building a mesothelioma specialty program at AdventHealth Orlando. “We want to make this a nationally — and internationally — recognized program,” DaSilva told The Mesothelioma Center at Asbestos.com. “People who come to Orlando will not only see Disney World, but they will see excellence in health care. We can do that here.” DaSilva was named chi...
Source: Asbestos and Mesothelioma News - December 3, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Report: 1.5 Million UK Buildings Contain Asbestos [Infographic]
Asbestos may have been banned in the United Kingdom 20 years ago, but the deadly carcinogen continues to be the leading cause of occupational death, leading to 5,500 deaths in the U.K. last year. According to a new report by ResPublica, an estimated six million tons of the deadly carcinogen remain inside 1.5 million buildings in the U.K., including schools and hospitals — many of which were built prior to the 1999 ban. Exposure to asbestos is directly connected to multiple diseases, including mesothelioma, lung cancer and asbestosis. Jump to the full infographic: Asbestos Risk in UK Hospital...
Source: Asbestos and Mesothelioma News - November 27, 2019 Category: Environmental Health Authors: Daniel King Source Type: news

Latest Mesothelioma Clinical Trial Opens at Memorial Sloan Kettering
Memorial Sloan Kettering Cancer Center in New York City has opened its latest clinical trial for patients with pleural mesothelioma, studying the effectiveness of an immunotherapy and chemotherapy combination prior to aggressive surgery. The novel feasibility study will determine if the use of Opdivo (nivolumab) with Alimta (pemetrexed) and either cisplatin or carboplatin — without delaying scheduled surgery — can significantly extend patient survival time. The hope is to duplicate earlier effectiveness of that same combination with other cancers. “It has been tried with promising results,” Memorial...
Source: Asbestos and Mesothelioma News - November 27, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Celebrities Paint Masks for Mesothelioma Fundraising Event
The goal of the Pacific Mesothelioma Center is to be the most innovative nonprofit research and cancer treatment organization in the world. Its latest fundraising event is a perfect example. As part of the Pacific Heart, Lung & Blood Institute, the Pacific Mesothelioma Center will play a major role in the unMASKing the Cure for Cancer Gala, an innovative fundraising idea once used by Prince Charles more than 20 years ago. The November 21 event, held at the UCLA Luskin Conference Center, includes the auctioning of eclectic masks that were hand-painted by various celebrities, including actors, artists, athletes and music...
Source: Asbestos and Mesothelioma News - November 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Johnson & Johnson Rushed Tests of Asbestos in Baby Powder
A new report reveals Johnson & Johnson rushed the test results of its iconic baby powder to show it was free of asbestos contamination. The Wall Street Journal reported Sunday that two independent laboratories found no evidence of asbestos in the same recalled lot of baby powder used in the U.S Food and Drug Administration report last month. But evidence shows the quick turnaround on the tests may have impacted results. One of those laboratories, commissioned by J&J after the FDA report, initially found asbestos in the talc sample, but quickly recanted. It told J&J the sample had been contaminated by the air...
Source: Asbestos and Mesothelioma News - November 18, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Death from 9/11 Signals Start of Things to Come
Malignant mesothelioma has become the latest deadly cancer linked directly to the rescue, recovery and cleanup efforts following the 9/11 terrorist attack on New York City in 2001. The long-running threat has come to fruition. Eighteen years after Manhattan was engulfed in the asbestos-laced, toxic cloud of dust — caused primarily by the World Trade Center destruction — the first death from pleural mesothelioma attributed to 9/11 has been recorded. Nick Ursta, 52, from the southwestern part of Pennsylvania, died after a year-long battle with the rare cancer. Ursta, a construction worker and fireman by trade, w...
Source: Asbestos and Mesothelioma News - November 14, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

EPA Leaving Libby Asbestos Superfund Site to Montana
The U.S. Environmental Protection Agency is leaving the Libby Asbestos Superfund site, but that doesn’t mean the job is finished. It’s just changing hands. The Montana Department of Environmental Quality will assume the oversight role of the Superfund site, which was part of the longest-running, man-made environmental disaster in American history. The EPA spent almost two decades decontaminating Libby and nearby Troy, Montana, a massive project stemming from the vermiculite mine operation that once spread asbestos dust throughout the region, sickening both miners and residents throughout Lincoln County. More th...
Source: Asbestos and Mesothelioma News - November 11, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Miami Cancer Institute Begins Using Novel Treatment for Mesothelioma
The Miami Cancer Institute on Thursday will begin using the innovative Tumor Treating Fields device for patients with malignant pleural mesothelioma. It is the first new treatment approved for mesothelioma by the U.S. Food and Drug Administration in more than 15 years. “This is actually pretty exciting for us,” Dr. Rupesh Kotecha, the radiation oncologist who will oversee the treatment protocol in Miami, told The Mesothelioma Center at Asbestos.com. “It’s another tool in our armamentarium. It’s something we can offer patients that has shown a real benefit.” The noninvasive Tumor Treating...
Source: Asbestos and Mesothelioma News - November 6, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Major Retailers Pull J & J Baby Powder After FDA Finds Asbestos
Major retailers have stopped selling the 22-ounce bottles of Johnson & Johnson baby powder after last week’s announcement that the U.S. Food and Drug Administration found traces of asbestos in one of the containers. Exposure to asbestos, a naturally occurring mineral and known carcinogen, is the primary cause of malignant mesothelioma, a rare and aggressive cancer with no definitive cure. Walmart, CVS Pharmacy and Rite Aid were among the many retailers that have pulled the product from shelves as part of the voluntary recall. “We always put customer safety first and foremost,” Chris Savarese, Rite Aid...
Source: Asbestos and Mesothelioma News - October 25, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Tumor Treating Fields Showing Early Success for Mesothelioma
Dr. Giovanni Ceresoli doesn’t think Tumor Treating Fields will work for every patient with mesothelioma cancer, but he knows it will work for some. They are in his clinic. As the principal investigator of the multicenter clinical trial that led to approval by the U.S. Food and Drug Administration in May, Ceresoli has played a major role in the development of this latest mesothelioma treatment. “It might be too early to say this is a major breakthrough — we need more data — but I hope it is. I know it’s something promising, very promising,” Cerosoli told The Mesothelioma Center at Asbest...
Source: Asbestos and Mesothelioma News - October 23, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

J & J Recalls Baby Powder After FDA Finds Asbestos
Johnson & Johnson announced a voluntary recall on Friday of an estimated 33,000 bottles of its iconic baby powder after the U.S. Food and Drug Administration found traces of asbestos in a bottle purchased recently from an online retailer. The company also said that it was working closely with federal authorities to determine the validity of the test results and the integrity of the tested sample. FDA testing indicated sub-trace levels of chrysotile asbestos contamination, defined as no greater than 0.00002%, according to the announcement. Exposure to asbestos, a naturally occurring mineral and known carcinogen, is the ...
Source: Asbestos and Mesothelioma News - October 18, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Case Study Shows Asbestos in Talc Causes Mesothelioma
This study was the first large case series to identify contaminated cosmetic talc as the cause of mesothelioma and the first to use background controls dictated by no known asbestos exposure. It emphasizes the continued risk from common cosmetic products once thought to be safe for all. “I would tell people that there is no regulation for talc, and that if there is a safer alternative, than I would advise them to do that,” Moline said. “I would not recommend people use talcum powder.” The post Case Study Shows Asbestos in Talc Causes Mesothelioma appeared first on Mesothelioma Center - Vital Service...
Source: Asbestos and Mesothelioma News - October 18, 2019 Category: Environmental Health Authors: Daniel King Source Type: news

Effective Second-Line Treatment for Mesothelioma Gaining Ground
Doctors at the Swiss Group for Clinical Cancer Research in Zurich, Switzerland, have uncovered a novel, anti-tumor compound that could become a needed second-line treatment for pleural mesothelioma cancer. Their recent multicenter phase II clinical trial conducted in Switzerland and Italy revealed the safety and efficacy of lurbinectedin, a synthetically produced agent that inhibits the growth of mesothelioma cells. “We believe this could represent a new treatment option for pleural mesothelioma,” Dr. Yannis Metaxas, oncologist at Kantonsspital Graubunden outside Zurich, told The Mesothelioma Center at Asbestos...
Source: Asbestos and Mesothelioma News - October 17, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

New York ’s MTA Ignored Asbestos Dangers for Years
Glaring safety issues involving asbestos exposure within the Metropolitan Transportation Authority extend further than the East New York bus depot in Brooklyn, a report from the agency’s inspector general alleges. Inhaling or ingesting tiny asbestos fibers in the air can lead to serious health conditions later in life, including mesothelioma cancer. The inspector general report, released Monday, shows MTA managers ignored asbestos safety concerns at bus and train facilities across New York City for years. Asbestos-containing materials were found in disrepair in the boiler rooms of at least six MTA depots throughout...
Source: Asbestos and Mesothelioma News - October 8, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Keytruda for Mesothelioma Flops in Phase III Clinical Trial
Results from a phase III clinical trial comparing Keytruda (pembrolizumab) to standard chemotherapy shows the immunotherapy drug still has a long way to go as a viable treatment option for malignant pleural mesothelioma. Keytruda did not improve progression-free survival for mesothelioma patients who progressed after first-line chemotherapy. The disappointing results from the PROMISE-meso study were presented at the European Society of Medical Oncology (ESMO) annual meeting last week. It was the first randomized trial comparing progression-free survival between immunotherapy and first-line chemotherapy for mesothelioma p...
Source: Asbestos and Mesothelioma News - October 7, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

First Mesothelioma Patient Begins Newly Approved Treatment
A mesothelioma patient at West Cancer Center in Memphis, Tennessee, is the first in the country to use NovoTTF-100L, a noninvasive electric therapy treatment, since its approval by the U.S. Food and Drug Administration in May. The FDA’s approval of Novocure’s Tumor Treating Fields device for the treatment of mesothelioma marked the first new FDA-approved treatment option for the rare asbestos-related cancer in more than 15 years. NovoTTF-100L uses a low-voltage electrical field that is distributed with three pads attached to the front and back of a person’s chest. The electrical current is designed to di...
Source: Asbestos and Mesothelioma News - October 1, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Inspector General Report: Asbestos Exposure a Concern on Army Posts
Residents in privatized housing on nearly 50 Army installations cited concerns with issues such as lead paint and asbestos, the toxic building material linked to mesothelioma cancer, according to a recent report from the Department of the Army Inspector General. The report, which was made public earlier this month, includes surveys, document reviews and interviews with residents at 49 Army installations across the U.S., including Fort Bragg (N.C.), Fort Campbell (Ky.) and Fort Hood in Texas. Military families at 48 of the 49 sites cited concerns with safety or environmental issues inside the aging on-base housing at the ...
Source: Asbestos and Mesothelioma News - September 25, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Medicare Now Covers CAR T-Cell Therapy for Approved Cancers
A promising and expensive type of immunotherapy, called CAR T-cell therapy, is now covered by Medicare. This news may affect mesothelioma patients in the future. Chimeric antigen receptor T-cell, or CAR T-cell, therapy involves the laboratory reprogramming of a patient’s T cells, which are a type of white blood cell responsible for protecting the body against infection and disease. The T cells are genetically modified to better recognize and attack cancer. The U.S. Food and Drug Administration has approved the immunotherapy procedure for non-Hodgkin lymphoma and B-cell precursor acute lymphoblastic leukemia. It is...
Source: Asbestos and Mesothelioma News - September 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Cells Slowed by Grape-Seed Extracts
Extracts from two Italian grape varieties showed distinct anti-cancer activity in three different mesothelioma cell lines, according to a recent multicenter study in Naples, Italy. The in-vitro findings strongly suggest potential of a novel, nonconventional mesothelioma treatment advancement in the future for this aggressive, difficult-to-treat cancer. Previous laboratory studies have shown a negative impact of grape-seed extracts on breast, colon and skin cancer cells, but this was the first using multiple human mesothelioma cell lines. “Our study on mesothelioma seems very promising, but it is a preliminary analysi...
Source: Asbestos and Mesothelioma News - September 12, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Asbestos in Makeup Leads to Recall of City Color Products
Beauty Plus Global Inc., the cosmetics and packaging manufacturer behind City Color and Max Mell, has issued a voluntary recall of four City Color makeup products that tested positive for asbestos contamination. The U.S. Food and Drug Administration announced the recall Friday in the agency’s latest advisory regarding asbestos-contaminated cosmetics. The four recalled City Color products include: Beauty Plus Global Inc. City Color Collection Matte Blush (Fuchsia) — SKU #849136008807, Lot No. 1605020/PD-840 Beauty Plus Global Inc. City Color Cosmetics Timeless Beauty Palette — SKU #849136012958,...
Source: Asbestos and Mesothelioma News - September 9, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Clinical Trial Targets Latest Gene Therapy
Pioneering pulmonologists Dr. Steven Albelda and Dr. Daniel Sterman have worked for more than 20 years on developing gene therapy to effectively combat pleural mesothelioma cancer. The payoff may have finally arrived. Albelda and Sterman’s long-awaited, phase III clinical trial will open this month to evaluate the efficacy of TR002, a novel gene therapy drug, when used in combination with celecoxib and gemcitabine. TR002, a form of immunotherapy, is a genetically engineered adenovirus that triggers the anti-tumor effects of interferon, a naturally occurring protein that destroys cancer cells. “The hope is, if i...
Source: Asbestos and Mesothelioma News - September 4, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

MD Anderson Remains Top-Ranked Cancer Center
U.S. News & World Report named University of Texas MD Anderson Cancer Center in Houston as the No. 1 Adult Cancer Hospital in America for the fifth consecutive year. Memorial Sloan-Kettering Cancer Center in New York, Mayo Clinic in Rochester, Minnesota, Johns Hopkins Hospital in Baltimore and Dana-Farber/Brigham and Women’s Cancer Center in Boston, round out the top five, respectively. All five have highly regarded specialty centers for pleural mesothelioma, the rare and aggressive cancer caused by the inhalation of asbestos fibers. The expertise in mesothelioma treatment contributed to the top rankings in the 2...
Source: Asbestos and Mesothelioma News - August 28, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Study Explores New Treatment When Chemotherapy Fails
A clinical trial is exploring whether a novel immunotherapy/antiangiogenic combination can serve as an effective second-line treatment for pleural mesothelioma. Early indications of the four-center, phase II clinical trial are positive. The combination involves nivolumab (Opdivo) , a well-known immunotherapy drug, and ramucirumab (Cyramza), a therapy drug that blocks the formation of blood vessels needed for new tumor growth. The Food and Drug Administration approved both drugs for the treatment of other cancers, but this clinical trial is the first to test them in combination for mesothelioma. The single-arm trial began i...
Source: Asbestos and Mesothelioma News - August 26, 2019 Category: Environmental Health Authors: Walter Pacheco Source Type: news

White House Asbestos Risk Forces Top Staff Relocation
The offices of some of President Donald Trump’s top aides, including his daughter Ivanka Trump and senior counselor Kellyanne Conway, have been temporarily relocated as the White House undergoes asbestos abatement work. An asbestos removal project is underway at 1600 Pennsylvania Avenue and is expected to be completed by the end of August. The abatement work will cost about $250,000, according to Pamela Pennington, press secretary for the U.S. General Services Administration. “The building has been, and remains, safe for occupancy as this work is being done as a precautionary measure,” Pennington said. I...
Source: Asbestos and Mesothelioma News - August 22, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Clinical Trial Offering Personalized Immunotherapy for Mesothelioma
Patients with mesothelioma are now eligible for a multicancer clinical trial studying the effectiveness of personalized immunotherapy at the University of California, San Diego Medical Center. The phase I clinical trial involves a combination of Keytruda (pembrolizumab), a proven immunotherapy drug, and an individualized vaccine based upon the genetic mutations found in each patient’s cancer. “This is the future of cancer treatment,” Dr. Ezra Cohen, principal investigator and director of the San Diego Center for Precision Immunotherapy, told The Mesothelioma Center at Asbestos.com. “Now, we still ha...
Source: Asbestos and Mesothelioma News - August 14, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Australian Study Shows Treatment Advances for Peritoneal Mesothelioma
Patients with peritoneal mesothelioma undergoing a second cytoreductive surgery had a median survival of 92 months, according to a recent study at St. George Hospital and the University of South Wales in Sydney, Australia. That same group of patients also had a five-year survival rate of 71.8%, further illustrating the progress being made in treating the peritoneal subtype of this rare and aggressive cancer. The Journal of Surgical Oncology published the study in July 2019. The single-center study detailed the survival benefits of cytoreduction and perioperative intraperitoneal chemotherapy in colorectal, ovarian, appendic...
Source: Asbestos and Mesothelioma News - August 12, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Baylor Opens New Immunotherapy Clinical Trial for Mesothelioma
The Baylor College of Medicine in Houston has opened its latest clinical trial for mesothelioma patients to study the effectiveness of a novel immunotherapy combination. The nonsurgical, single-center study is looking for a dozen patients whose pleural mesothelioma has progressed after at least one regimen of chemotherapy. The phase II clinical trial involves Opdivo (nivolumab) and MTG201, a modified adenovirus designed to increase the efficacy of certain types of immunotherapy drugs. The combination was especially effective in preclinical mouse models. “We’re excited about the prospects of this combination,&rd...
Source: Asbestos and Mesothelioma News - August 7, 2019 Category: Environmental Health Authors: Walter Pacheco Source Type: news

Mesothelioma Treatment in Toronto Moves from SMART to SMARTER
The Princess Margaret Cancer Center in Toronto has moved from SMART to SMARTER with the recent launch of its latest clinical trial for pleural mesothelioma patients. SMARTER is the acronym for Surgery for Mesothelioma After Radiation Therapy using Extensive pleural Resection, which also describes the latest clinical trial. The phase I clinical trial is an unconventional approach to treatment of mesothelioma: Find the maximum tolerated dosage of hypofractionated radiation to stimulate the immune system before aggressive surgery. It comes on the heels of the SMART protocol, which stands for Surgery for Mesothelioma After Rad...
Source: Asbestos and Mesothelioma News - July 31, 2019 Category: Environmental Health Authors: Walter Pacheco Source Type: news

Once-Promising Drug Ofev Fails in Mesothelioma Clinical Trial
The search for a cure of mesothelioma hit another roadblock recently when a once-promising immunotherapy drug, combined with standard chemotherapy, failed to slow disease progression in a phase III study. The multicenter study covering 27 countries involved Ofev (nintedanib), a small-molecule enzyme inhibitor drug that had shown considerable potential in earlier studies. Lancet Respiratory Medicine published the trial results, signaling another setback for the highly anticipated use of certain immunotherapy drugs to treat mesothelioma. “Making significant improvements in systemic therapy for malignant pleural mesothe...
Source: Asbestos and Mesothelioma News - July 30, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Trump Signs 9/11 Victims Fund Extension
President Donald Trump on Monday signed legislation that will extend the September 11th Victim Compensation Fund until 2092. During the signing ceremony at the White House, Trump was surrounding by first responders, survivors and family members of several who died in the 2001 terrorist attack on the United States. The U.S. House of Representatives and the U.S Senate voted overwhelmingly last week to approve the legislation that will provide a lifetime of assistance for victims and their families. The extension will allow the fund, first established in 2001, to pay for past and future medical claims of those effected by the...
Source: Asbestos and Mesothelioma News - July 29, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Cameron Sees No Need for National Mesothelioma Registry
Thoracic surgeon Dr. Robert Cameron, a longtime leader in the fight against pleural mesothelioma cancer, believes there is no benefit to establishing a government-funded national registry for the disease. While many of his colleagues support the idea of creating the first National Mesothelioma Registry, Cameron feels the time, effort and money spent would be better used elsewhere in helping patients. The National Institute of Occupational Safety and Health is currently conducting a National Mesothelioma Registry feasibility study for this rare and aggressive cancer. As part of that feasibility study, NIOSH opened a public ...
Source: Asbestos and Mesothelioma News - July 25, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

9/11 Victims Fund Passes Senate
The Senate gallery erupted in applause from politicians and first responders on Tuesday after a 97-2 vote to extend the September 11 Victim Compensation Fund until 2092. The reauthorization will fund all current and future medical claims of those effected by the 9/11 terrorist attacks on the World Trade Center in New York City, the Pentagon in Washington, and United Flight 93, which crashed in Shanksville, Pennsylvania. The extension will allow victims and their families to file claims through 2090, but they will be paid out through 2092. The extension of funding will benefit victims who may develop mesothelioma linked to ...
Source: Asbestos and Mesothelioma News - July 23, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Senate Passes 9/11 Victim Compensation Fund Extension
The U.S. Senate followed the House of Representatives on Tuesday and passed legislation that will extend the September 11 Victim Compensation Fund until 2092. The legislation will fund all current and future medical claims of those effected by the 9/11 terrorist attacks on the World Trade Center in New York City, the Pentagon in Washington, and United Flight 93, which crashed in Shanksville, Pennsylvania. The extension of funding will benefit victims who may develop mesothelioma linked to the more than 400 tons of asbestos that covered the 16-acre disaster zone after the twin towers fell. According to World Trade Center R...
Source: Asbestos and Mesothelioma News - July 23, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Death Rate Still Rising in Great Britain
Despite banning all forms and uses of asbestos 20 years ago, Great Britain still has one of the world’s highest rates of mesothelioma cancer, according to the government’s Health and Safety Executive report. The July 2019 report revealed the number of annual deaths from mesothelioma in the country still is peaking and expected to begin a gradual decline in 2020. The report included 2,523 deaths in 2017 (the last year available) from mesothelioma, the rare and aggressive cancer caused by exposure to asbestos. It estimates as many as 2,637 others could die in 2019. Great Britain, which comprises the nations of E...
Source: Asbestos and Mesothelioma News - July 22, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Radiotherapy No Longer Routine for Mesothelioma Patients
Prophylactic radiotherapy — once offered routinely after invasive procedures for pleural mesothelioma — is an unnecessary treatment for patients, according to the most recent study from the United Kingdom. Results from a large, multicenter clinical trial have shown the treatment — used regularly for almost two decades — does little to prevent chest-wall metastasis that can occur with mesothelioma cancer. “This should be helpful for patients to know if their oncologist is offering something they don’t really need,” clinical oncologist Dr. Neil Bayman, associate medical director at t...
Source: Asbestos and Mesothelioma News - July 16, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

J & J Faces Criminal Probe over Asbestos in Baby Powder
The U.S. Justice Department is conducting a criminal investigation to determine if Johnson & Johnson misled the public about the possible presence of asbestos fibers and the resulting cancer risk in its talcum powder. According to Bloomberg News, a federal grand jury is examining whether company officials knew and denied their product once contained trace amounts of the toxic mineral. An ongoing regulatory investigation and thousands of lawsuits have coincided with the latest probe of the pharmaceutical giant. Johnson & Johnson is the world’s largest manufacturer of talc products, including its iconic Baby Po...
Source: Asbestos and Mesothelioma News - July 15, 2019 Category: Environmental Health Authors: Walter Pacheco Source Type: news

Beagles Diagnosing Cancer ‘Could Work with Mesothelioma’
Specially trained beagles could one day detect mesothelioma by scent, according to the lead researcher of a recent study detailing the dog breed’s stunning accuracy with lung cancer. Dr. Thomas Quinn, clinical professor at the Lake Erie College of Osteopathic Medicine, believes the dogs could be equally effective with pleural mesothelioma, a rare cancer caused by asbestos exposure. “Absolutely, this could work with mesothelioma. There is no reason why it wouldn’t,” Quinn told The Mesothelioma Center at Asbestos.com. “That is another cancer with strong potential for this to work well.” Th...
Source: Asbestos and Mesothelioma News - July 10, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Avastin Improves Quality of Life for Mesothelioma Patients
A research team from France has documented the health-related quality-of-life benefits of adding Avastin (bevacizumab) to chemotherapy for pleural mesothelioma patients, endorsing its addition to standard-of-care treatment. The recent quality-of-life analysis was a secondary endpoint of an earlier, multicenter clinical trial in France that showed an almost three-month median survival improvement when adding Avastin. The latest study demonstrated that adding Avastin to cisplatin and Alimta (pemetrexed) did not negatively impact quality of life — a problem with several other cancers because of the increased toxicity. &...
Source: Asbestos and Mesothelioma News - July 8, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

States File Lawsuit Against EPA Over Asbestos Regulation
A coalition of attorneys general from 10 states and the District of Columbia has filed a federal lawsuit against the Environmental Protection Agency seeking increased scrutiny on asbestos products. The lawsuit is challenging the EPA’s reluctance to initiate tighter controls or an outright ban of asbestos within the Toxic Substances Control Act, which was revised in 2016. At issue is the EPA’s denial of a petition filed by 15 attorneys general in January that would have required more data collection and tracking of chemicals, including asbestos, coming into the U.S. The lawsuit says the data collection is necess...
Source: Asbestos and Mesothelioma News - July 3, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Asbestos Found in Lungs of Half the Thailand Population
Almost 50% of the general population in Thailand will die with at least traces of asbestos in their lungs, based on one recent study. Asbestos fibers were discovered in the lungs of 48.5% of those who were part of a one-year, post-mortem analysis done by the Department of Pathology at Ramathibodi Hospital, Mahidol University in Bangkok. The toxic mineral was found during 97 of the 200 autopsies that were performed at the hospital without regard to occupation, age, sex or cause of death. A two-year-old infant, who died of congenital heart disease, was the youngest to have asbestos identified in the lungs. “The prevale...
Source: Asbestos and Mesothelioma News - July 1, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

New Compound Could Make Chemotherapy More Effective
A research team from the Duke University Medical Center and the Massachusetts Institute of Technology has uncovered a new compound with potential to make chemotherapy more effective in treating various cancers. The small-molecule inhibitor drug — JH-RE-06 — showed an ability to better-sensitize tumors to Cisplatin, the popular chemotherapy drug most often used for mesothelioma cancer patients. When combined with Cisplatin, the drug also showed an ability to prevent those tumor cells from becoming treatment resistant, a common problem with this rare cancer caused by asbestos exposure. The research was done on l...
Source: Asbestos and Mesothelioma News - June 27, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Chlor-Alkali Industry Wants Exception to Proposed US Asbestos Ban
The influential American Chemistry Council in Washington, D.C., would likely drop its opposition to an across-the-board ban on asbestos provided an exemption remains for the chlor-alkali industry. Mike Walls, ACC vice president for regulatory affairs, clarified his position last month during a congressional Environment and Climate Change subcommittee hearing to discuss the latest legislative effort to ban all asbestos. “We certainly are not opposing a ban for all other uses of asbestos. I just want to make that clear,” Walls said. “The ACC’s opposition [on legislation] is focused on the impact on t...
Source: Asbestos and Mesothelioma News - June 25, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Colombia Ban of Asbestos Sets Example for US to Follow
Linda Reinstein was not surprised by the news last week that Colombia had joined the growing list of more than 60 countries to legislate a ban of asbestos. She saw it coming when she spoke on the topic at the University of Rosario in Bogota, Colombia, almost a year ago. She felt the intense passion there to prevent more innocent lives being lost to asbestos-related diseases such as mesothelioma. “It was another experience where the heartache, grief and anger of asbestos victims all came together and turned into action to facilitate change,” Reinstein, president and CEO of the Asbestos Disease Awareness Organiza...
Source: Asbestos and Mesothelioma News - June 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study Begins to Develop Breath Test for Mesothelioma Early Detection
This study has terrific significance and could be extremely important,” Harbut, clinical professor of internal medicine at Wayne State University and Michigan State University, told The Mesothelioma Center at Asbestos.com. “We’re going after this one with great guns.” The study is part of a new partnership between Owlstone Medical — the Breath Biopsy inventor in the United Kingdom — and the International Association of Heat and Frost Insulators and Allied Workers, a building trade union that covers the United States and Canada. Early Diagnosis Still a Rarity The first part of the study ...
Source: Asbestos and Mesothelioma News - June 18, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Long-Term 9/11 Funding Bill Moves Closer to Reality
The House Judiciary Committee passed the Never Forget the Heroes bill Wednesday that will extend the 9/11 Victim Compensation Fund until 2090. The bill would ensure all victims of the Sept. 11 terrorist attacks — and their families — will be compensated throughout their lives. It now must pass the full House of Representatives and the Senate before it can be signed into law by the president. The extension would especially help any 9/11 victims, first responders or bystanders that may develop mesothelioma linked to the estimated 400 tons of asbestos that was released in New York City after the twin towers fell....
Source: Asbestos and Mesothelioma News - June 13, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study Combines PD-1 and CAR-T Immunotherapy to Treat Mesothelioma
At the 2019 American Society of Clinical Oncology annual meeting, Dr. Prasad Adusumilli from Memorial Sloan Kettering Cancer Center shared exciting new results from his study on combination immunotherapy for malignant pleural mesothelioma. Among the 18 mesothelioma patients in the study, 14 received a combination of two different immunotherapy treatments. Eleven of this group experienced a complete response, a partial response or stable disease. The latest results from this phase 1 clinical trial were presented June 4. They demonstrate the promise of using two immunotherapy approaches at one time. Phase 1 studies are desi...
Source: Asbestos and Mesothelioma News - June 13, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Treatment Guidelines Not Followed Often Enough
Too many patients with pleural mesothelioma are going without treatment recommended by National Comprehensive Cancer Network guidelines, according to a recent study at Cedars-Sinai Medical Center in Los Angeles. Valuable survival time is being lost. The Annals of Thoracic Surgery published the study that looked at disparities in compliance with national treatment guidelines and their impact on overall survival. The National Comprehensive Cancer Network, along with the American Society of Clinical Oncology, recommends multimodal therapy — surgery, chemotherapy and possibly radiation therapy — for mesothelioma pa...
Source: Asbestos and Mesothelioma News - June 12, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news